Kenvue (KVUE) Expected to Release Earnings on Thursday

Kenvue (NYSE:KVUE) is anticipated to announce its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Kenvue to post earnings of $0.3188 per share and revenue of $3.9660 billion for the quarter. Interested persons may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter in the previous year, the company posted $0.24 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. On average, analysts expect Kenvue to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Kenvue Stock Performance

Shares of KVUE stock opened at $19.77 on Thursday. Kenvue has a fifty-two week low of $14.02 and a fifty-two week high of $22.35. The stock’s 50-day moving average is $18.52 and its two-hundred day moving average is $17.98. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The firm has a market cap of $37.97 billion, a P/E ratio of 23.26, a PEG ratio of 1.50 and a beta of 0.47.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 4.2%. The ex-dividend date of this dividend is Wednesday, August 12th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Wall Street Zen raised shares of Kenvue to a “buy” rating in a research report on Sunday, July 12th. UBS Group increased their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. Barclays upped their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Finally, Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus price target of $19.58.

Insider Transactions at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.59% of the stock is owned by insiders.

Institutional Trading of Kenvue

Several large investors have recently modified their holdings of the company. Transamerica Financial Advisors LLC increased its stake in shares of Kenvue by 80.4% in the fourth quarter. Transamerica Financial Advisors LLC now owns 11,083 shares of the company’s stock worth $191,000 after purchasing an additional 4,939 shares during the period. Brooklyn Investment Group grew its stake in shares of Kenvue by 48.8% in the third quarter. Brooklyn Investment Group now owns 11,355 shares of the company’s stock worth $184,000 after acquiring an additional 3,724 shares during the last quarter. Two Sigma Investments LP bought a new position in shares of Kenvue during the 3rd quarter worth about $176,000. Sittner & Nelson LLC increased its stake in Kenvue by 410.0% during the third quarter. Sittner & Nelson LLC now owns 10,200 shares of the company’s stock valued at $166,000 after acquiring an additional 8,200 shares during the period. Finally, Banco BTG Pactual S.A. bought a new stake in shares of Kenvue in the 3rd quarter worth approximately $162,000. 97.64% of the stock is owned by institutional investors.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.